NY A00265 | 2025-2026 | General Assembly

Status

Spectrum: Bipartisan Bill
Status: Introduced on January 8 2025 - 25% progression
Action: 2025-01-10 - print number 265a
Pending: Assembly Alcoholism and Drug Abuse Committee
Text: Latest bill text (Amended) [HTML]

Summary

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.

Sponsors


History

DateChamberAction
2025-01-10Assemblyprint number 265a
2025-01-10Assemblyamend and recommit to alcoholism and drug abuse
2025-01-08Assemblyreferred to alcoholism and drug abuse

New York State Sources


Bill Comments

feedback